首页> 外文OA文献 >Comparison between MassARRAY and pyrosequencing for CYP2C19 and ABCB1 gene variants of clopidogrel efficiency genotyping

【2h】

Comparison between MassARRAY and pyrosequencing for CYP2C19 and ABCB1 gene variants of clopidogrel efficiency genotyping

机译：Cyp2C19对Cyp2C19和ABCB1基因变种的Massarray和焦肌序列的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Juan Liu; Zesheng Xu; Ya Li; Shipeng Dai; Junying Liu; Junjun Pan; Yang Jiang;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison between MassARRAY and pyrosequencing for CYP2C19 and ABCB1 gene variants of clopidogrel efficiency genotyping [J] . Juan Liu, Zesheng Xu, Ya Li, Molecular membrane biology. . 2019,第1期

机译：氯吡格雷效率基因分型的CYP2C19和ABCB1基因变异的MassARRAY和焦磷酸测序的比较
2. Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes [J] . CarlquistJ.F., KnightS., HorneB.D., Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2013,第4期

机译：CYP2C19和ABCB1基因的遗传变异改变了药物洗脱支架置入后接受氯吡格雷抗血小板治疗的患者的心血管风险
3. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. [J] . Mega JL, Close SL, Wiviott SD, The Lancet . 2010,第9749期

机译：TRITON-TIMI 38试验中使用氯吡格雷和普拉格雷治疗后ABCB1和CYP2C19的遗传变异以及心血管结局：药物遗传学分析。
4. Analysis of the CYP2C19*2 and *3 gene variants in a Romanian population [C] . Buzoianu A. D., Trifa A. P., Popp R. A., European Association for Clinical Pharmacology and Therapeutics . 2009

机译：罗马尼亚人群中CYP2C19 * 2和* 3基因变种分析
5. Microbial community analysis assessed by pyrosequencing of rRNA gene: Community comparisons, organism identification, and its enhancement. [D] . Sul, Woo Jun. 2009

机译：通过rRNA基因的焦磷酸测序评估的微生物群落分析：群落比较，生物鉴定及其增强。
6. Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel [O] . Roberta Galeazzi, Fabiola Olivieri, Liana Spazzafumo, -1

机译：ABCB1和CYP2C19基因变异的聚类预测了接受阿司匹林和氯吡格雷双重抗血小板治疗的老年急性冠脉综合征患者的主要出血和血栓事件的风险
7. Polymorphism of CYP2C19 and ABCB1 genes associated with changes in the activity of clopidogrel in patients with ischemic stroke: clinical and ethnic aspects [O] . D.A. Sychev, V.V. Shprakh, E.Yu. Kitaeva, 2019

机译：CYP2C19和ABCB1基因的多态性与缺血性卒中患者氯吡格雷活性的变化相关：临床和族裔方面

Comparison between MassARRAY and pyrosequencing for CYP2C19 and ABCB1 gene variants of clopidogrel efficiency genotyping

著录项

引文网络

相似文献

相关主题

期刊订阅